26.03 - Ndays 2025 _ Brochure_Clinical_Cases - Flipbook - Page 134
CLINICAL CASE
The use of growth factor-based & active
ingredients therapy in the immediate
post-co2 laser period and following
Dr. Stefan Vasilevski
Master in Aesthetic Medicine
pih: a split-face case report
Resident in Dermatology,
North Macedonia
REPORT SUMMARY
PATIENT
A 48-year-old female underwent fullface fractional CO2 laser resurfacing,
evaluated with a split-face design.
TREATMENTS
Both sides received standard postlaser care, while one additionally
received Neauvia Recovery Mask
immediately and at 12 h, followed by
Neauvia Ceramide Serum at 24 h. The
NON-TREATED SIDE
treated side showed faster reduction
in erythema, vascularity, thickness, and
stiffness, with visibly less redness, lower
pain, earlier “white line” recovery, and
reduced PIH risk.
RESULTS
This demonstrates that growth factors
and ceramides accelerate healing,
reduce downtime, and enhance comfort
post-laser.
TREATED SIDE
COSMECEUTICALS
INSTANT RECOVERY MASK
CERAMIDE SHIELD SERUM
Neauvia products are for trained experts only. Use must follow approved indications and the Instructions for Use (IFU) in accordance to
applicable laws and regulations in each country. Physicians are solely responsible for any treatments outside these conditions. The results
shown are specific to an individual treatment plan. Treatment decisions must be adapted to each patient, who may respond differently
based on numerous factors. Outcomes are variable and not guaranteed.
132
